Differential biological activity of disease-associated JAK2 mutants.

Abstract excerpt

The JAK2V617F mutation has been identified in most patients with myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia and primary myelofibrosis. Although JAK2V617F is the predominant allele associated with MPNs, other activating Janus kinase 2 (JAK2) alleles (such as K539L, T875N) also have been identified in distinct MPNs. The basis for the differences in the in vivo...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cell Line
• Share to Disease
• Share to Erythroid Precursor Cells